% | $
Quotes you view appear here for quick access.

DSW Inc. Message Board

bigoldman55 4 posts  |  Last Activity: Oct 15, 2015 6:02 PM Member since: May 15, 2002
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • bigoldman55 bigoldman55 Oct 15, 2015 6:02 PM Flag

    According to the Economist, Horizon Pharma increased the cost of Vimovo by about 600 % in 2013 after purchase from AstraZeneca. Since price movement of HZNP has been strongly correlated to price movement of VRX recently , I think scrutiny of companies who institute sharp increases in drug prices (what is currently plaguing VRX stock price) is probably a more valid reason for the underperformance of HZNP in the weak biotech group than the Depomed proposed merger or hedge fund manipulation. In any event, I wasn't aware of this until I read the Economist article.

  • bigoldman55 bigoldman55 Oct 8, 2015 3:15 PM Flag

    That seems logical. I'm guessing that the hedge funds were overexposed as well, and now are taking the opposite path to force all biotechs and especially Horizon down. I'll be glad when they move on, but for now the chart damage for almost all of my favorites is severely damaged, so I'll have to wait until bases start to form. I guess there will be opportunities in the sector in the future, and I would think that the depressed prices would be causing some of the major pharmas significant salivation.

  • I'm wondering if anyone has thoughts on why HZNP seems to be among the worst performing stocks in the biotech group. I sold HZNP 14 in January for a 9% gain (big mistake), but fortunately sold DEPO at 32.75 for a 44% gain. I am starting to get interested, but the technical damage looks so bad and I already have alot of biotech stocks---so I'm not willing to commit until it tries to base for awhile.

    Just curious, as HZNP seems to have among the highest growth rates in the group.

    Sentiment: Hold

  • Reply to

    $85 target

    by robmengnny Sep 11, 2015 2:40 PM
    bigoldman55 bigoldman55 Sep 11, 2015 3:31 PM Flag

    Vectorvest has a value of $141 for AMAG. This is my 2nd largest position, and I'm not selling. There have been alot of A+ funds in IBD that have added to AMAG recently. My basis is 34.

24.02+0.51(+2.17%)Nov 25 4:03 PMEST